Abstract
The integration of early ADMET (absorption, distribution, metabolism, excretion and toxicity) profiling, or simply prediction, of lead molecules to speed-up the lead selection further for phase-I trial without losing large amount of revenue. The ADMET profiling and prediction is mostly dependent of a number of molecular descriptors, for example, Lipinskis Rule of 5 (Ro5). Recently a large number of articles have been reporting that it possible to do some prediction of the ADMET properties using the structural features of the molecules, utilizing several and multiple approaches. One of the most important approaches is the QSAR/QSPR modelling of the data derived from their activity profiles and their different structural features (i.e., quantitative molecular descriptors).
Keywords: ADMET, drugability, molecular descriptor, QSAR modeling, logP, logD, artificial neural network, PSA, multiple linear regressions, machine learning, support vector machine, inductive logic programming
Current Drug Metabolism
Title: Predictions of the ADMET Properties of Candidate Drug Molecules Utilizing Different QSAR/QSPR Modelling Approaches
Volume: 11 Issue: 4
Author(s): Mahmud Tareq Hassan Khan
Affiliation:
Keywords: ADMET, drugability, molecular descriptor, QSAR modeling, logP, logD, artificial neural network, PSA, multiple linear regressions, machine learning, support vector machine, inductive logic programming
Abstract: The integration of early ADMET (absorption, distribution, metabolism, excretion and toxicity) profiling, or simply prediction, of lead molecules to speed-up the lead selection further for phase-I trial without losing large amount of revenue. The ADMET profiling and prediction is mostly dependent of a number of molecular descriptors, for example, Lipinskis Rule of 5 (Ro5). Recently a large number of articles have been reporting that it possible to do some prediction of the ADMET properties using the structural features of the molecules, utilizing several and multiple approaches. One of the most important approaches is the QSAR/QSPR modelling of the data derived from their activity profiles and their different structural features (i.e., quantitative molecular descriptors).
Export Options
About this article
Cite this article as:
Tareq Hassan Khan Mahmud, Predictions of the ADMET Properties of Candidate Drug Molecules Utilizing Different QSAR/QSPR Modelling Approaches, Current Drug Metabolism 2010; 11 (4) . https://dx.doi.org/10.2174/138920010791514306
DOI https://dx.doi.org/10.2174/138920010791514306 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Recent Advances in the Probe Development of Technetium-99m Molecular Imaging Agents
Current Organic Synthesis Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases
Current Topics in Medicinal Chemistry Gold Nanoparticle Based Systems in Genetics
Current Pharmacogenomics Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression
Current Medicinal Chemistry [131I]IAZA as a Molecular Radiotherapeutic (MRT) Drug: Wash-Out with Cold IAZA Accelerates Clearance in a Murine Tumor Model
Current Radiopharmaceuticals Vitiligo in Children: A Birds Eye View
Current Pediatric Reviews Fatty Acid-Mediated Inhibition of Metal Binding to the Multi-Metal Site on Serum Albumin: Implications for Cardiovascular Disease
Current Topics in Medicinal Chemistry MicroRNA: Biogenesis, Function and Role in Cancer
Current Genomics Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma
Current Drug Targets The Emergence of Non-coding RNAs as Versatile and Efficient Therapeutic Tools
Current Gene Therapy Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets From 2D to 3D - a New Dimension for Modelling the Effect of Natural Products on Human Tissue
Current Pharmaceutical Design Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers
Current Cancer Drug Targets The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
Current Stem Cell Research & Therapy Novel Anticancer Targets and Drug Discovery in Post Genomic Age
Current Medicinal Chemistry - Anti-Cancer Agents Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Current Pharmaceutical Biotechnology